Lance  Berberian net worth and biography

Lance Berberian Biography and Net Worth

Lance Berberian has served as Executive Vice President and Chief Information and Technology Officer since 2014. 

Prior to joining Labcorp, he served as the chief information officer at IDEXX Laboratories, Inc., a global leader in diagnostics and IT solutions for animal health and food and water quality. Lance also worked as chief information officer and president of Kellstrom Defense Aerospace Inc., a fully integrated supply chain firm, from 2000 to 2007. Prior to that, he was the chief information officer of Interim HealthCare Inc. 

Lance serves as chair of the strategic advisory board for North Carolina State University’s Department of Computer Science and an advisory board member for the University of North Carolina-Greensboro Master of Science in Informatics and Analytics. He also serves on the Board of Trustees for Elon University. Lance holds a B.S. in both business administration and information technology from Thomas Edison State College.

What is Lance Berberian's net worth?

The estimated net worth of Lance Berberian is at least $3.51 million as of August 5th, 2024. Mr. Berberian owns 15,921 shares of Laboratory Co. of America stock worth more than $3,507,874 as of September 11th. This net worth evaluation does not reflect any other assets that Mr. Berberian may own. Additionally, Mr. Berberian receives a salary of $876,620.00 as EVP at Laboratory Co. of America. Learn More about Lance Berberian's net worth.

How old is Lance Berberian?

Mr. Berberian is currently 61 years old. There are 8 older executives and no younger executives at Laboratory Co. of America. The oldest executive at Laboratory Co. of America is Ms. Sandra D. van der Vaart, Executive VP, Chief Legal Officer, Chief Compliance Officer & Corporate Secretary, who is 64 years old. Learn More on Lance Berberian's age.

What is Lance Berberian's salary?

As the EVP of Laboratory Co. of America Holdings, Mr. Berberian earns $876,620.00 per year. There are 5 executives that earn more than Mr. Berberian. The highest earning executive at Laboratory Co. of America is Mr. Adam H. Schechter, President, CEO & Chairman, who commands a salary of $4,660,000.00 per year. Learn More on Lance Berberian's salary.

How do I contact Lance Berberian?

The corporate mailing address for Mr. Berberian and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Lance Berberian's contact information.

Has Lance Berberian been buying or selling shares of Laboratory Co. of America?

Within the last three months, Lance Berberian has sold $2,770,506.30 in shares of Laboratory Co. of America stock. Most recently, Lance Berberian sold 12,093 shares of the business's stock in a transaction on Monday, August 5th. The shares were sold at an average price of $229.10, for a transaction totalling $2,770,506.30. Following the completion of the sale, the executive vice president now directly owns 15,921 shares of the company's stock, valued at $3,647,501.10. Learn More on Lance Berberian's trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, insiders at the medical research company sold shares 18 times. They sold a total of 90,307 shares worth more than $19,790,066.68. The most recent insider tranaction occured on August, 19th when EVP Der Vaart Sandra D Van sold 2,000 shares worth more than $454,100.00. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 8/19/2024.

Lance Berberian Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/5/2024Sell12,093$229.10$2,770,506.3015,921View SEC Filing Icon  
8/30/2019Sell5,902$169.80$1,002,159.606,097View SEC Filing Icon  
5/22/2017Sell3,613$139.84$505,241.925,789View SEC Filing Icon  
See Full Table

Lance Berberian Buying and Selling Activity at Laboratory Co. of America

This chart shows Lance Berberian's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $220.33
Low: $214.86
High: $228.31

50 Day Range

MA: $219.57
Low: $199.35
High: $236.00

2 Week Range

Now: $220.33
Low: $191.97
High: $238.46

Volume

778,359 shs

Average Volume

688,561 shs

Market Capitalization

$18.50 billion

P/E Ratio

44.33

Dividend Yield

1.29%

Beta

1.06